Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · February 22, 2022

Mast Cell–Produced Prostaglandin E2 Reduces SERT in IBS

Gastroenterology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Gastroenterology
Mucosal serotonin reuptake transporter (SERT) expression in IBS is modulated by gut microbiota via mast cell-prostaglandin E2
Gastroenterology 2022 Feb 12;[EPub Ahead of Print], J Gao, T Xiong, G Grabauskas, C Owyang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading